280 related articles for article (PubMed ID: 31267034)
1. Inhibition of Cathepsin S Reduces Lacrimal Gland Inflammation and Increases Tear Flow in a Mouse Model of Sjögren's Syndrome.
Klinngam W; Janga SR; Lee C; Ju Y; Yarber F; Shah M; Guo H; Wang D; MacKay JA; Edman MC; Hamm-Alvarez SF
Sci Rep; 2019 Jul; 9(1):9559. PubMed ID: 31267034
[TBL] [Abstract][Full Text] [Related]
2. Rapamycin Eye Drops Suppress Lacrimal Gland Inflammation In a Murine Model of Sjögren's Syndrome.
Shah M; Edman MC; Reddy Janga S; Yarber F; Meng Z; Klinngam W; Bushman J; Ma T; Liu S; Louie S; Mehta A; Ding C; MacKay JA; Hamm-Alvarez SF
Invest Ophthalmol Vis Sci; 2017 Jan; 58(1):372-385. PubMed ID: 28122086
[TBL] [Abstract][Full Text] [Related]
3. Imbalanced Rab3D versus Rab27 increases cathepsin S secretion from lacrimal acini in a mouse model of Sjögren's Syndrome.
Meng Z; Edman MC; Hsueh PY; Chen CY; Klinngam W; Tolmachova T; Okamoto CT; Hamm-Alvarez SF
Am J Physiol Cell Physiol; 2016 Jun; 310(11):C942-54. PubMed ID: 27076615
[TBL] [Abstract][Full Text] [Related]
4. Longitudinal analysis of tear cathepsin S activity levels in male non-obese diabetic mice suggests its potential as an early stage biomarker of Sjögren's Syndrome.
Janga SR; Shah M; Ju Y; Meng Z; Edman MC; Hamm-Alvarez SF
Biomarkers; 2019 Feb; 24(1):91-102. PubMed ID: 30126300
[TBL] [Abstract][Full Text] [Related]
5. Phenylephrine increases tear cathepsin S secretion in healthy murine lacrimal gland acinar cells through an alternative secretory pathway.
Fu R; Janga S; Edman MC; Hamm-Alvarez SF
Exp Eye Res; 2021 Oct; 211():108760. PubMed ID: 34487726
[TBL] [Abstract][Full Text] [Related]
6. Rab27a Contributes to Cathepsin S Secretion in Lacrimal Gland Acinar Cells.
Fu R; Edman MC; Hamm-Alvarez SF
Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33562815
[TBL] [Abstract][Full Text] [Related]
7. Cathepsin S activation contributes to elevated CX3CL1 (fractalkine) levels in tears of a Sjögren's syndrome murine model.
Fu R; Guo H; Janga S; Choi M; Klinngam W; Edman MC; Hamm-Alvarez SF
Sci Rep; 2020 Jan; 10(1):1455. PubMed ID: 31996771
[TBL] [Abstract][Full Text] [Related]
8. Lymphotoxin-beta receptor blockade reduces CXCL13 in lacrimal glands and improves corneal integrity in the NOD model of Sjögren's syndrome.
Fava RA; Kennedy SM; Wood SG; Bolstad AI; Bienkowska J; Papandile A; Kelly JA; Mavragani CP; Gatumu M; Skarstein K; Browning JL
Arthritis Res Ther; 2011; 13(6):R182. PubMed ID: 22044682
[TBL] [Abstract][Full Text] [Related]
9. Lacrimal gland fluid secretion and lymphocytic infiltration in the NZB/W mouse model of Sjögren's syndrome.
Paranyuk Y; Claros N; Birzgalis A; Moore LC; Brink PR; Walcott B
Curr Eye Res; 2001 Sep; 23(3):199-205. PubMed ID: 11803482
[TBL] [Abstract][Full Text] [Related]
10. Degradation of proteoglycan 4/lubricin by cathepsin S: Potential mechanism for diminished ocular surface lubrication in Sjögren's syndrome.
Regmi SC; Samsom ML; Heynen ML; Jay GD; Sullivan BD; Srinivasan S; Caffery B; Jones L; Schmidt TA
Exp Eye Res; 2017 Aug; 161():1-9. PubMed ID: 28549901
[TBL] [Abstract][Full Text] [Related]
11. Improvement of lacrimal function by topical application of CyA in murine models of Sjögren's syndrome.
Tsubota K; Fujita H; Tadano K; Takeuchi T; Murakami T; Saito I; Hayashi Y
Invest Ophthalmol Vis Sci; 2001 Jan; 42(1):101-10. PubMed ID: 11133854
[TBL] [Abstract][Full Text] [Related]
12. Tumor necrosis factor inhibitor gene expression suppresses lacrimal gland immunopathology in a rabbit model of autoimmune dacryoadenitis.
Zhu Z; Stevenson D; Schechter JE; Mircheff AK; Crow RW; Atkinson R; Ritter T; Bose S; Trousdale MD
Cornea; 2003 May; 22(4):343-51. PubMed ID: 12792478
[TBL] [Abstract][Full Text] [Related]
13. A rapamycin-binding protein polymer nanoparticle shows potent therapeutic activity in suppressing autoimmune dacryoadenitis in a mouse model of Sjögren's syndrome.
Shah M; Edman MC; Janga SR; Shi P; Dhandhukia J; Liu S; Louie SG; Rodgers K; Mackay JA; Hamm-Alvarez SF
J Control Release; 2013 Nov; 171(3):269-79. PubMed ID: 23892265
[TBL] [Abstract][Full Text] [Related]
14. Interferon-γ treatment in vitro elicits some of the changes in cathepsin S and antigen presentation characteristic of lacrimal glands and corneas from the NOD mouse model of Sjögren's Syndrome.
Meng Z; Klinngam W; Edman MC; Hamm-Alvarez SF
PLoS One; 2017; 12(9):e0184781. PubMed ID: 28902875
[TBL] [Abstract][Full Text] [Related]
15. Altered balance of interleukin-13/interferon-gamma contributes to lacrimal gland destruction and secretory dysfunction in CD25 knockout model of Sjögren's syndrome.
Bian F; Barbosa FL; Corrales RM; Pelegrino FS; Volpe EA; Pflugfelder SC; de Paiva CS
Arthritis Res Ther; 2015 Mar; 17(1):53. PubMed ID: 25889094
[TBL] [Abstract][Full Text] [Related]
16. Tear cathepsin S as a candidate biomarker for Sjögren's syndrome.
Hamm-Alvarez SF; Janga SR; Edman MC; Madrigal S; Shah M; Frousiakis SE; Renduchintala K; Zhu J; Bricel S; Silka K; Bach D; Heur M; Christianakis S; Arkfeld DG; Irvine J; Mack WJ; Stohl W
Arthritis Rheumatol; 2014 Jul; 66(7):1872-81. PubMed ID: 24644101
[TBL] [Abstract][Full Text] [Related]
17. Increased expression of cathepsins and obesity-induced proinflammatory cytokines in lacrimal glands of male NOD mouse.
Li X; Wu K; Edman M; Schenke-Layland K; MacVeigh-Aloni M; Janga SR; Schulz B; Hamm-Alvarez SF
Invest Ophthalmol Vis Sci; 2010 Oct; 51(10):5019-29. PubMed ID: 20463324
[TBL] [Abstract][Full Text] [Related]
18. Aire-deficient mice provide a model of corneal and lacrimal gland neuropathy in Sjögren's syndrome.
Chen FY; Lee A; Ge S; Nathan S; Knox SM; McNamara NA
PLoS One; 2017; 12(9):e0184916. PubMed ID: 28926640
[TBL] [Abstract][Full Text] [Related]
19. Supra-lacrimal protein-based carriers for cyclosporine A reduce Th17-mediated autoimmunity in murine model of Sjögren's syndrome.
Guo H; Ju Y; Choi M; Edman MC; Louie SG; Hamm-Alvarez SF; MacKay JA
Biomaterials; 2022 Apr; 283():121441. PubMed ID: 35306230
[TBL] [Abstract][Full Text] [Related]
20. NOD and NOR mice exhibit comparable development of lacrimal gland secretory dysfunction but NOD mice have more severe autoimmune dacryoadenitis.
Ju Y; Janga SR; Klinngam W; MacKay JA; Hawley D; Zoukhri D; Edman MC; Hamm-Alvarez SF
Exp Eye Res; 2018 Nov; 176():243-251. PubMed ID: 30201519
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]